KO
44
2
PGR
63
3
CTSH
54
-2
XEL
69
2
AMAT
42
6
LMT
32
-12
JWN
42
2
XRX
41
6
SEE
52
6
MA
57
2
AMZN
55
-3
AXP
69
3
ETN
79
4
RIG
58
4
PEG
67
5
BSX
70
2
OKE
81
3
HRL
41
2
WHR
64
3
ISRG
76
2
KO
44
2
PGR
63
3
CTSH
54
-2
XEL
69
2
AMAT
42
6
LMT
32
-12
JWN
42
2
XRX
41
6
SEE
52
6
MA
57
2
AMZN
55
-3
AXP
69
3
ETN
79
4
RIG
58
4
PEG
67
5
BSX
70
2
OKE
81
3
HRL
41
2
WHR
64
3
ISRG
76
2
Financhill
Back

Clearside Biomedical Vs. Perspective Therapeutics Industry Stock Comparison

Sell
31

CLSD
Clearside Biomedical

Last Price:
1.07
Seasonality Move:
25.1%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.47
Seasonality Move:
34.33%
Sell
31
Clearside Biomedical (CLSD) is a Sell

Is Clearside Biomedical a Buy, Sell or Hold?

  • The current Clearside Biomedical [CLSD] share price is $1.02. The Score for CLSD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CLSD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLSD Stock Price Chart

What is Clearside Biomedical's stock price today?

  • The Clearside Biomedical share price today is $1.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLSD is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

CLSD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 42.23 Sell
Chaikin Money Flow: -160613 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.01 - 1.15) Sell
Bollinger Bands (100): (1.02 - 1.26) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

CLSD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.04 Sell
20-day SMA: 1.06 Sell
50-day SMA: 1.18 Sell
200-day SMA: 1.25 Sell
8-day EMA: 1.04 Sell
20-day EMA: 1.08 Sell
50-day EMA: 1.12 Sell
200-day EMA: 1.19 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

Clearside Biomedical Earnings Growth & CLSD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Clearside Biomedical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):